Prognostic value of interleukin-6 in atrial fibrillation: A cohort study and meta-analysis

Xiaoyue Jia1, Xi Cheng2, Na Wu1

  • 1Department of Epidemiology, College of Preventive Medicine, Army Medical University (Third Military Medical University); Chongqing-People's Republic of China;Evidence-based Medicine and Clinical Epidemiology Center, Army Medical University (Third Military Medical University); Chongqing-People's Republic of China.

Insights

Elevated interleukin-6 (IL-6) levels predict stroke and mortality in atrial fibrillation (AF) patients. Adding IL-6 to the CHA2DS2-VASc score may improve AF management strategies.

Area of Science:

  • Cardiology
  • Biomarkers
  • Clinical Research

Background:

  • Interleukin-6 (IL-6) is a pro-inflammatory cytokine.
  • Its prognostic value in atrial fibrillation (AF) requires further clarification.
  • AF is a common arrhythmia associated with increased risk of stroke and mortality.

Purpose of the Study:

  • To assess the predictive value of IL-6 for stroke and mortality in AF patients.
  • To evaluate the incremental prognostic value of IL-6 when added to the CHA2DS2-VASc score.
  • To validate these associations through a meta-analysis.

Main Methods:

  • A cohort study of 217 newly diagnosed non-valvular AF patients followed for 27 months.
  • Multivariate Cox regression analysis to assess IL-6 association with stroke and mortality.
  • Meta-analysis of existing cohort studies and the current study.

Main Results:

  • Elevated IL-6 was an independent predictor of stroke (HR=3.81) and mortality (HR=3.11) in the cohort.
  • Adding IL-6 to CHA2DS2-VASc score showed improved stroke prediction (AUC 0.81 to 0.88).
  • Meta-analysis confirmed IL-6 association with increased stroke (pooled HR=1.97) and mortality (pooled HR=2.73) risk.

Conclusions:

  • Increased IL-6 levels are significantly linked to higher stroke and mortality risks in AF patients.
  • IL-6 may serve as a valuable biomarker to refine AF risk stratification.
  • Incorporating IL-6 into risk scores could aid in managing AF treatment.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
41
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
112
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
64
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.5K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
68